A tale of two yeasts: Saccharomyces cerevisiae as a therapeutic against candidiasis

References

• Sobel JD. Vulvovaginal candidosis. Lancet 2007; 369:1961-71; PMID:17560449; http://dx.doi.org 10.1016/S0140-6736(07)60917-9
   PubMed Web of Science ®Google Scholar
• Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013; 13:790-801; PMID:24096337; http://dx.doi.org 10.1038/nri3535
   PubMed Web of Science ®Google Scholar
• Byrd AL, Segre JA. Infectious disease. Adapting Koch's postulates. Science 2016; 351:224-6; PMID:26816362; http://dx.doi.org 10.1126/science.aad6753
   PubMed Web of Science ®Google Scholar
• Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015; 517:205-8; PMID:25337874; http://dx.doi.org 10.1038/nature13828
   PubMed Web of Science ®Google Scholar
• Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemoth 2006; 58:266-72; http://dx.doi.org 10.1093/jac/dkl246
   PubMed Web of Science ®Google Scholar
• Pericolini E, Gabrielli E, Ballet N, Sabbatini S, Roselletti E, Cayzeele Decherf A, Pelerin F, Luciano E, Perito S, Justen P, et al. Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis. Virulence 2017; 8(1):74-90; http://dx.doi.org/10.1080/21505594.2016.1213937
   Google Scholar
• Jacobsen ID, Wilson D, Wachtler B, Brunke S, Naglik JR, Hube B. Candida albicans dimorphism as a therapeutic target. Expert Rev Anti-Infect Ther 2012; 10:85-93; PMID:22149617; http://dx.doi.org 10.1586/eri.11.152
   PubMed Web of Science ®Google Scholar
• Wachtler B, Wilson D, Haedicke K, Dalle F, Hube B. From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PloS One 2011; 6:e17046; PMID:21407800; http://dx.doi.org 10.1371/journal.pone.0017046
   PubMed Web of Science ®Google Scholar
• Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, Welch WH, Ibrahim AS, Edwards JE, Jr., Filler SG. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 2007; 5:e64; PMID:17311474; http://dx.doi.org 10.1371/journal.pbio.0050064
   PubMed Web of Science ®Google Scholar
• Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2006; 2:e129
   PubMed Web of Science ®Google Scholar
• Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence 2013; 4:119-28; PMID:23302789; http://dx.doi.org 10.4161/viru.22913
   PubMed Web of Science ®Google Scholar
• Moyes DL, Wilson D, Richardson JP, Mogavero S, Tang SX, Wernecke J, Hofs S, Gratacap RL, Robbins J, Runglall M, et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 2016; PMID:27027296
   PubMed Web of Science ®Google Scholar
• Moyes DL, Murciano C, Runglall M, Islam A, Thavaraj S, Naglik JR. Candida albicans yeast and hyphae are discriminated by MAPK signaling in vaginal epithelial cells. PloS One 2011; 6:e26580; PMID:22087232; http://dx.doi.org 10.1371/journal.pone.0026580
   PubMed Web of Science ®Google Scholar
• Fidel PL, Jr., Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, Quayle AJ, Dunlap K. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 2004; 72:2939-46; PMID:15102806; http://dx.doi.org 10.1128/IAI.72.5.2939-2946.2004
   PubMed Web of Science ®Google Scholar
• Wachtler B, Wilson D, Hube B. Candida albicans adhesion to and invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole. Antimicrob Agents Chemother 2011; 55:4436-9; PMID:21746947; http://dx.doi.org 10.1128/AAC.00144-11
   PubMed Web of Science ®Google Scholar
• Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003; 67:400-28, table of contents; PMID:12966142; http://dx.doi.org 10.1128/MMBR.67.3.400-428.2003
   PubMed Web of Science ®Google Scholar
• Pericolini E, Gabrielli E, Amacker M, Kasper L, Roselletti E, Luciano E, Sabbatini S, Kaeser M, Moser C, Hube B, et al. Secretory aspartyl proteinases cause vaginitis and can mediate vaginitis caused by Candida albicans in mice. mBio 2015; 6:e00724; PMID:26037125; http://dx.doi.org 10.1128/mBio.00724-15
   PubMed Web of Science ®Google Scholar